Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Botulism has been known for about three centuries, and since its discovery, botulinum toxin
has been considered one of the most powerful toxins. However, throughout the 20th century …

Sixty-seven percent of children with cerebral palsy (CCP) experience pain. Pain is closely
interrelated to diminished quality of life. Despite this, pain is an overlooked and undertreated …

IncobotulinumtoxinA, a pure botulinumtoxinA formulation, is free of accessory proteins. This
analysis provides pooled safety data from phase 3 trials of children/adolescents (2–17 …

PURPOSE: Investigate the efficacy and safety of multipattern incobotulinumtoxinA injections
in children/adolescents with lower-limb cerebral palsy (CP)-related spasticity. METHODS …

Cerebral palsy (CP) is one of the most common conditions leading to lifelong childhood
physical disability. Literature reported previously altered muscle properties such as lower …

Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Background: Muscles from patients with cerebral palsy (CP) are often spastic and form
contractures that limit the range of motion. Injections of botulinum toxin A (BTX) into the calf …

Dystonia is the most common movement disorder in the pediatric population. It can affect
normal motor development and cause significant motor disability. The treatment of pediatric …

Pain and quality of life are closely interrelated in children with cerebral palsy (CCP). Even
though 67% of CCP experience pain, it is overlooked and untreated. In this study, our …